Mark Van Oene reports PACB insider sales
Mark Van Oene reported sales of Common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mark Van Oene reported sales of Common stock. The filing lists two transactions: 02/17/2026 sale of 129,790 shares for $204,549.04 and 02/18/2026 sale of 55,107 shares for $89,769.30. The filing also lists Restricted Stock to be sold on 03/02/2026.
Insights
Reported insider sales by Mark Van Oene on consecutive dates.
The filing itemizes two open-market sales: $204,549.04 for 129,790 shares on 02/17/2026 and $89,769.30 for 55,107 shares on 02/18/2026. These amounts are stated verbatim in the excerpt.
Timing and motivation are not disclosed in the excerpt; subsequent filings may provide context. Cash‑flow recipients are the selling holder as shown; the excerpt also lists restricted stock planned for sale on 03/02/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What sales did Mark Van Oene report for PACB?
Does the filing show any planned sales for PACB restricted stock?
Who is the broker or intermediary shown in the Form 144?
Are the sale proceeds and dates provided in the PACB excerpt?
AI-generated analysis. How Rhea-AI works. Not financial advice.